glp-1 receptor agonist type 1 diabetes randomized trial agonists and diabetic retinopathy: A meta-analysis of clinical trials GLP-1 receptor agonists and cardiovascular

Safety, Personalization, and the Cenegenics Approach The rapid growth of peptide use has also brought confusion and misinformation

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): A 56-week, double-blind, phase 3a, randomised trial

For research-peptide users, this is the single most important data drop since the original NEJM Phase 2 paper by Jastreboff and colleagues in 2023

FDA has also discussed ipamorelin acetate safety concerns in compounding, including immunogenicity risks related to aggregation or peptide-related impurities and the complexity of characterization

237 Similarly, KD enhanced the effectiveness of anti-CTLA-4 immunotherapy by reducing PD-L1 protein levels and augmenting the expression of interferons and antigen presentation-related genes

Allium tuberosum alleviates pulmonary inflammation by inhibiting activation of innate lymphoid cells and modulating intestinal microbiota in asthmatic mice